Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, Illinois.
Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, Illinois.
J Heart Lung Transplant. 2021 Aug;40(8):745-753. doi: 10.1016/j.healun.2021.04.004. Epub 2021 Apr 21.
The microbiome is an environmental factor in intricate symbiotic relationship with its hosts' immune system, potentially shaping anticancer immunity, autoimmunity, and transplant responses. The focus of this review is to discuss recent findings tying the microbiota to transplant outcomes and alloimmunity. The microbiota changes dynamically following transplantation, but whether these changes affect transplant outcomes can be difficult to parse out. New data reveal effects of the microbiota locally, as well as systemically, depending on the mucosal/epithelial surface colonized, the specific commensal communities present and the nature of microbial-derived molecules produced. These complex interactions result in the microbiota potentially impacting transplantation at different levels, including modulation of donor and/or recipient cells, alterations in the priming and/or effector phases of the alloimmune response, availability or metabolism of immunosuppressive drugs, transplant fate or post-transplant complications.
微生物组是与宿主免疫系统处于复杂共生关系的环境因素,可能影响抗肿瘤免疫、自身免疫和移植反应。本综述的重点是讨论将微生物组与移植结果和同种异体免疫联系起来的最新发现。微生物组在移植后会发生动态变化,但这些变化是否会影响移植结果可能难以解析。新数据揭示了微生物组在局部和全身的影响,这取决于定植的黏膜/上皮表面、存在的特定共生群落以及产生的微生物衍生分子的性质。这些复杂的相互作用导致微生物组可能在不同层面上影响移植,包括调节供体和/或受体细胞、改变同种免疫反应的启动和/或效应阶段、免疫抑制剂药物的可用性或代谢、移植结局或移植后并发症。